SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001144204-17-040470
Filing Date
2017-08-04
Accepted
2017-08-04 10:18:23
Documents
2
Effectiveness Date
2017-08-04

Document Format Files

Seq Description Document Type Size
1 POS EX v472410_posex.htm POS EX 30740
2 EXHIBIT 99.1 v472410_ex99-1.htm EX-99.1 2630
  Complete submission text file 0001144204-17-040470.txt   34370
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-203133 | Film No.: 171007267
SIC: 2834 Pharmaceutical Preparations